Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fungal mitochondrial complex I, also known as mitochondrial NADH:ubiquinone oxidoreductase, is the largest and first enzyme complex in the mitochondrial electron transport chain[1][6][9]. It is embedded in the inner mitochondrial membrane and comprises both conserved and fungal-specific protein subunits[1][3][4][5]. Complex I catalyzes electron transfer from NADH (generated during metabolism) to ubiquinone, coupling this reaction to the translocation of protons across the membrane, which establishes a proton gradient used by ATP synthase for energy production[1][6][9]. In fungi, unique subunits of complex I can regulate additional processes such as cell wall biosynthesis and virulence[3][5][10]. Mutations or inhibition of this complex can impair fungal growth, lead to hypersensitivity to antifungal agents, and attenuate pathogenicity, which validates mitochondrial complex I as a promising target for antifungal drug development[3][5][6][8][10]. Targeting fungal-specific elements of this complex may allow development of selective antifungal therapies with reduced host toxicity[3][5][6].
Inhibition of electron transfer from NADH to ubiquinone, blocking ATP synthesis\n- Disruption of proton translocation across the inner mitochondrial membrane\n- Induction of oxidative stress due to increased production of reactive oxygen species (ROS)\n- Destabilization of cell wall synthesis and impairment of energy-intensive processes in fungi
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial NADH:ubiquinone oxidoreductase (fungal) (Complex I).